西山 博之(ニシヤマ ヒロユキ)
- 論文
- Indications for fertility preservation not included in the 2017 Japan Society of Clinical Oncology Guideline for Fertility Preservation in Pediatric, Adolescent, and Young Adult Patients treated with gonadal toxicity, including benign diseases
Ono Masanori; Matsumoto Kimikazu; Boku Narikazu; Fujii...
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY/27(4)/pp.825-826, 2021-11 - Phase I/II study to evaluate the efficacy of TAS0313, a cancer peptide vaccine, combined with pembrolizumab for locally advanced or metastatic urothelial carcinoma.
Matsumoto Ryuji; Yonese Junji; Kawahara Takashi; Miyake ...
JOURNAL OF CLINICAL ONCOLOGY/39(15::S), 2021-05 - KEYNOTE-B15/EV-304: Randomized phase 3 study of perioperative enfortumab vedotin plus pembrolizumab versus chemotherapy in cisplatin-eligible patients with muscle-invasive bladder cancer (MIBC).
Hoimes Christopher J.; Bedke Jens; Loriot Yohann; Nishiya...
JOURNAL OF CLINICAL ONCOLOGY/39(15::S), 2021-05 - IMvigor011: A global, double-blind, randomised phase III study of atezolizumab (atezo; anti-PD-L1) vs placebo (pbo) as adjuvant therapy in patients (pts) with high-risk muscle-invasive bladder cancer (MIBC) who are circulating tumour (ct)DNA plus post cystectomy
Powles T. B.; Gschwend J. E.; Bracarda S.; Castellano D....
ANNALS OF ONCOLOGY/32(5)/pp.S721-S721, 2021 - KEYNOTE-676 cohort B: Randomized comparator-controlled cohort to evaluate efficacy and safety of pembrolizumab (pembro) plus bacillus Calmette-Guerin (BCG) in patients with high-risk BCG treatment-naive non-muscle invasive bladder cancer (HR NMIBC)
Shariat S. F.; Steinberg G.; Kamat A. M.; Shore N. D.; Al...
ANNALS OF ONCOLOGY/32(5)/pp.S723-S723, 2021 - Current status and future perspectives of immunotherapy against urothelial and kidney cancer
Kobayashi Takashi; Takeuchi Ario; Nishiyama Hiroyuki; ...
JAPANESE JOURNAL OF CLINICAL ONCOLOGY/51(10)/pp.1481-1492, 2021-10 - Impact of the objective response to and number of cycles of platinum-based first-line chemotherapy for metastatic urothelial carcinoma on overall survival of patients treated with pembrolizumab
Kato Minoru; Kobayashi Takashi; Matsui Yoshiyuki; Ito ...
INTERNATIONAL JOURNAL OF UROLOGY/Epub, 2021-09 - Prevalence of Germline Variants in a Large Cohort of Japanese Patients with Pheochromocytoma and/or Paraganglioma
Yonamine Masato; Wasano Koichiro; Aita Yuichi; Sugasaw...
CANCERS/13(16), 2021-08 - Impact of Early Exposure to Simulation Program on Undergraduate Medical Students' Interest in Urology
Kimura Tomokazu; Kojo Kosuke; Shiga Masanobu; Chihara Ic...
JOURNAL OF MEDICAL EDUCATION AND CURRICULAR DEVELOPMENT/8, 2021-05 - Bacillus Calmette-Guerin-unresponsive non-muscle invasive bladder cancer outcomes in patients without radical cystectomy
Iida Kota; Miyake Makito; Murakami Kaoru; Komiyama Mo...
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY/26(11)/pp.2104-2112, 2021-11 - Outcomes of axitinib versus sunitinib as first-line therapy to patients with metastatic renal cell carcinoma in the immune-oncology era
Numakura Kazuyuki; Muto Yumin; Naito Sei; Hatakeyama Shi...
CANCER MEDICINE/10(17)/pp.5839-5846, 2021-09 - Is real-time detection based on probability map of bladder tumor possible in clinic cystoscopy using deep learning?
Ikeda A.; Kochi Y.; Nosato H.; Negoro H.; Sakanashi H.; M...
EUROPEAN UROLOGY/79(1)/pp.S1756-S1756, 2021-06 - Novel metastatic burden-stratified risk model in de novo metastatic hormone-sensitive prostate cancer
Shiota Masaki; Terada Naoki; Kitamura Hiroshi; Kojima Ta...
CANCER SCIENCE/112(9)/pp.3616-3626, 2021-09 - Impact of histological variants on outcomes in patients with urothelial carcinoma treated with pembrolizumab: a propensity score matching analysis
Kobayashi Mizuki; Narita Shintaro; Matsui Yoshiyuki; K...
BJU INTERNATIONAL/Epub, 2021-06 - Pembrolizumab monotherapy for the treatment of high-risk non-muscle-invasive bladder cancer unresponsive to BCG (KEYNOTE-057): an open-label, single-arm, multicentre, phase 2 study
Balar Arjun V; Kamat Ashish M.; Kulkarni Girish S.; Uc...
LANCET ONCOLOGY/22(7)/pp.919-930, 2021-07 - Pre-pembrolizumab neutrophil-to-lymphocyte ratio (NLR) predicts the efficacy of second-line pembrolizumab treatment in urothelial cancer regardless of the pre-chemo NLR
Kobayashi Takashi; Ito Katsuhiro; Kojima Takahiro; Mar...
CANCER IMMUNOLOGY IMMUNOTHERAPY/Epub, 2021-07 - Prognosis of Japanese metastatic renal cell carcinoma patients in the targeted therapy era
Naito Sei; Kato Tomoyuki; Numakura Kazuyuki; Hatakeyam...
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY/26(10)/pp.1947-1954, 2021-10 - Intravesical Bacillus Calmette-Guerin Treatment for T1 High-Grade Non-Muscle Invasive Bladder Cancer with Divergent Differentiation or Variant Morphologies
Miyake Makito; Nishimura Nobutaka; Iida Kota; Fujii T...
CANCERS/13(11), 2021-06 - Advanced germ cell tumor patients undergoing post-chemotherapy retroperitoneal lymph node dissection: Impact of residual teratoma on prognosis
Nitta Satoshi; Kawai Koji; Kimura Tomokazu; Kandori S...
INTERNATIONAL JOURNAL OF UROLOGY/28(8)/pp.840-847, 2021-08 - ctDNA guiding adjuvant immunotherapy in urothelial carcinoma
Powles Thomas; Assaf Zoe June; Davarpanah Nicole; Banc...
NATURE/595/pp.432-437, 2021-06 - Pembrolizumab for treating advanced urothelial carcinoma in patients with impaired performance status: Analysis of a Japanese nationwide cohort
Ito Katsuhiro; Kobayashi Takashi; Kojima Takahiro; Hik...
CANCER MEDICINE/10(10)/pp.3188-3196, 2021-05 - Discrepancy between clinical and pathological T stages in upper urinary tract urothelial carcinoma: Analysis of the Hospital-Based Cancer Registry data in Japan
Shiga Masanobu; Nagumo Yoshiyuki; Chihara Ichiro; Nitt...
INTERNATIONAL JOURNAL OF UROLOGY/28(8)/pp.814-819, 2021-08 - Perioperative pembrolizumab therapy in muscle-invasive bladder cancer: Phase III KEYNOTE-866 and KEYNOTE-905/EV-303
Galsky Matthew D.; Hoimes Christopher J.; Necchi Andre...
FUTURE ONCOLOGY/17(24)/pp.3137-3150, 2021-05 - A phase III, randomized, open-label, multicenter, global study of efficacy and safety of durvalumab in combination with gemcitabine plus cisplatin for neoadjuvant treatment followed by durvalumab alone for adjuvant treatment in muscle-invasive bladder cancer (NIAGARA).
Powles Thomas; Meeks Joshua J.; Galsky Matt D.; Van de...
JOURNAL OF CLINICAL ONCOLOGY/39(6::S), 2021-02 - The comparison of cytoreductive nephrectomy (CN) with tyrosine kinase inhibitor therapy alone in patients with primary metastatic renal cell carcinoma (mRCC).
Hatakeyama Shingo; Naito Sei; Numakura Kazuyuki; Kato Re...
JOURNAL OF CLINICAL ONCOLOGY/39(6::S), 2021-02 - さらに表示...
- Indications for fertility preservation not included in the 2017 Japan Society of Clinical Oncology Guideline for Fertility Preservation in Pediatric, Adolescent, and Young Adult Patients treated with gonadal toxicity, including benign diseases